Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document
 

Item 6.
Exhibits

Exhibit
Numbers
Description
   
3.1
Articles of Incorporation with all amendments (1)
   
3.2
By-Laws, as Amended (2)
   
10.1
Controlled Equity OfferingSM Sales Agreement, dated as of April 6, 2017, between BioTime, Inc. and Cantor Fitzgerald & Co. (3)
   
Second Amended and Restated License Agreement, dated June 15, 2017, between Cell Cure Neurosciences, Ltd. and Hadasit Medical Research Services and Development Ltd. (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) *
   
Debt and Note Purchase Agreement, dated June 16, 2017, as amended June 29, 2017, between BioTime, Inc. and HBL-Hadasit Bio-Holdings Ltd. (Portions of this exhibit have been omitted pursuant to a request for confidential treatment)*
   
Share Purchase and Transfer Agreement, dated June 16, 2017, by and among BioTime, Inc. and HBL-Hadasit Bio-Holdings Ltd. and Cell Cure Neurosciences Ltd. (Portions of this exhibit have been omitted pursuant to a request for confidential treatment)*
   
10.5
2017 Amendment to 2012 Equity Incentive Plan (4)
   
Rule 13a-14(a)/15d-14(a) Certification*
   
Section 1350 Certification*
   
101
Interactive Data Files
   
101.INS
XBRL Instance Document*
   
101.SCH
XBRL Taxonomy Extension Schema*
   
101.CAL
XBRL Taxonomy Extension Calculation Linkbase*
   
101.DEF
XBRL Taxonomy Extension Definition Document*
   
101.LAB
XBRL Taxonomy Extension Label Linkbase*
   
101.PRE
XBRL Taxonomy Extension Presentation Linkbase*
 
(1)
Incorporated by reference to BioTime’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 filed with the Securities and Exchange Commission on August 9, 2016.
(2)
Incorporated by reference to Registration Statement on Form S-1, File Number 33-48717 and Post-Effective Amendment No. 1 thereto filed with the Securities and Exchange Commission on June 22, 1992, and August 27, 1992, respectively.
(3)
Incorporated by reference to Registration Statement on Form S-3, File Number 333-217182, filed with the Securities and Exchange Commission on April 6, 2017.
(4)
Incorporated by reference to Registration Statement on Form S-8, File Number 333-219204, filed with the Securities and Exchange Commission on July 7, 2017.

*
Filed herewith

28

© Copyright BioTime, Inc.